store at low temperature,keep away from direct sunlight
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Alvespimycin (17-DMAG) is a potent Hsp90 inhibitor with potential anticancer activity, which acts by binding to Hsp90.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | In stock | $ 89.00 | |
10 mg | In stock | $ 143.00 | |
25 mg | In stock | $ 289.00 | |
50 mg | In stock | $ 428.00 | |
100 mg | In stock | $ 623.00 |
Description | Alvespimycin (17-DMAG) is a potent Hsp90 inhibitor with potential anticancer activity, which acts by binding to Hsp90. |
Targets&IC50 | HSP90:62 nM (EC50), GRP94:65 nM (EC50) |
In vitro | After treatment with vehicle control or 1 μM Alvespimycin (17-DMAG) for 24 hours, CLL patient cells showed that Alvespimycin downregulated NF-κB signaling through IKKα and IKKβ[2]. |
In vivo | Treatment with vehicle (DMSO) or Alvespimycin(17-DMAG)(10 mg/kg) significantly prolonged the survival time of TCL1-SCID model mice[2]. |
Synonyms | 17-DMAG, KOS1022, KOS 1022, KOS-1022 |
Molecular Weight | 616.75 |
Formula | C32H48N4O8 |
CAS No. | 467214-20-6 |
store at low temperature,keep away from direct sunlight
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 80 mg/mL (129.71 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Alvespimycin 467214-20-6 Cytoskeletal Signaling Metabolism HSP 17-DMAG KOS1022 KOS 1022 KOS-1022 inhibitor inhibit